Premier Dermatology Partners

CLIA Laboratory Citation Details

1
Total Citation
3
Total Deficiencyies
3
Unique D-Tags
CMS Certification Number 10D2292928
Address 5353 N Federal Highway, Suite 303, Fort Lauderdale, FL, 33308
City Fort Lauderdale
State FL
Zip Code33308
Phone(954) 860-7500

Citation History (1 survey)

Survey - August 15, 2025

Survey Type: Standard

Survey Event ID: 0ZE011

Deficiency Tags: D5291 D0000 D6091

Summary:

Summary Statement of Deficiencies D0000 A validation survey was conducted on August 15, 2025. Standard-level deficiencies were cited. D5291 GENERAL LABORATORY SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1239(a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and, when indicated, correct problems identified in the general laboratory systems requirements specified at 493.1231 through 493.1236. This STANDARD is not met as evidenced by: Based on review of the laboratory's Proficiency Testing and Quality Assurance policies, Proficiency Testing report/Peer Review for MOHS Micrographic Survey forms, and interview with the lead Medical Assistant, the laboratory failed to follow its established Quality Assurance policy and procedural requirements for one of one proficiency testing report/MOHS peer review. Findings included: 1. A review of the laboratory's Proficiency Testing Policy revealed the requirement of, "the peer review documentation will be signed and dated by: the reviewing MOHS Surgeon, Dermatologist, Pathologist or Dermatopathologist; the original MOHS Surgeon; and the Laboratory Director." 2. A review the laboratory's Proficiency Testing and Quality Assurance procedure specified, "Any comments documented during either the QA and Proficiency Testing will be reviewed and signed by the Lab Director." 3. A review of a master copy of the laboratory's Proficiency Testing report/Peer Review for MOHs Micrographic Surgery form showed a designated Lab Director Review Signature line. However, examination of a completed MOHs Micrographic Surgery form for Testing Personnel #1 (TP #1) covering the period January 2025 to June 2025 revealed the Lab Director Review Signature Line had been whited out and replaced with an electronic signature for TP #1. 4. During an interview conducted on 08/15/2025 at 11:30 AM, Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- the Lead Medical Assistant confirmed the laboratory failed to follow its own established Quality Assurance procedures by allowing TP #1 to sign their own peer review form and not the Laboratory Director. D6091 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(e)(4)(iii) (e)(4)(iii) All proficiency testing reports received are reviewed by the appropriate staff to evaluate the laboratorys performance and to identify any problems that require

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access